SCHEMBL808897

SCHEMBL808897

COc1ccc(C2C(=O)CCc3ccccc32)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GID4 Q8IVV7 2/20 0.55
MAPT P10636 2/20 0.51
HPGD P15428 2/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
MAOA P21397 1/20 0.51
PTGS2 P35354 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 2/20 0.45
CASP1 P29466 1/20 0.45
MPI P34949 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NPBWR1 P48145 1/20 0.44
EDNRA P25101 2/20 0.43
EDNRB P24530 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
OPRM1 P35372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14293862 0.85 CA1 (0.49) MAPTHPGDNPC1TP53MAOA
SCHEMBL9438607 0.84 GID4 (0.58) GID4MAPTNPC1ALDH1A1HDAC1
SCHEMBL16340316 0.83 PRCP (0.51) MAPTHPGDNPC1TP53ALDH1A1
SCHEMBL809758 0.82 CA1 (0.55) GID4DRD1
SCHEMBL1722733 0.82 GAA (0.51) MAPTHPGDTP53CYP1A2LMNA
SCHEMBL14267920 0.78 CA1 (0.56) KDM4E
SCHEMBL809757 0.78 CETP (0.51) MAPTHPGDALDH1A1KDM4ECASP1
SCHEMBL9797951 0.78 CETP (0.43) GID4RAB9ANPBWR1CYP2D6CETP
SCHEMBL9797956 0.78 CETP (0.43) GID4RAB9ANPBWR1CYP2D6CETP
SCHEMBL6826748 0.77 SLC6A2 (0.40) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2467202-B1 METHODS FOR SELECTIVELY SYNTHESIZING 1-ARYL-2-TETRALONES CORNING INC (US) 2017-04-19 EP disclosed
EP-2467202-B1 METHODS FOR SELECTIVELY SYNTHESIZING 1-ARYL-2-TETRALONES CORNING INC (US) 2017-04-19 EP disclosed
EP-2467202-A2 METHODS FOR SELECTIVELY SYNTHESIZING 1-ARYL-2-TETRALONES Corning Incorporated (US) 2012-06-27 EP disclosed
EP-1955992-B1 Process for the preparation of 1-aryl-3, 4-dihydro-1h-napthalene-2-one TOKUYAMA CORP (JP) 2011-11-23 EP disclosed
EP-1955992-B1 Process for the preparation of 1-aryl-3, 4-dihydro-1h-napthalene-2-one TOKUYAMA CORP (JP) 2011-11-23 EP disclosed
WO-2011022450-A2 METHODS FOR SELECTIVELY SYNTHESIZING 1-ARYL-2-TETRALONES CORNING INCORPORATED (US) 2011-02-24 WO disclosed
WO-2011022450-A2 METHODS FOR SELECTIVELY SYNTHESIZING 1-ARYL-2-TETRALONES CORNING INCORPORATED (US) 2011-02-24 WO disclosed
US-7829745-B1 Methods for selectively synthesizing 1-aryl-2-tetralones CORNING INCORPORATED (US) 2010-11-09 US disclosed
US-7829745-B1 Methods for selectively synthesizing 1-aryl-2-tetralones CORNING INCORPORATED (US) 2010-11-09 US disclosed
US-7829745-B1 Methods for selectively synthesizing 1-aryl-2-tetralones CORNING INCORPORATED (US) 2010-11-09 US disclosed
US-7728154-B2 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one TOKUYAMA CORPORATION (JP) 2010-06-01 US disclosed
US-7728154-B2 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one TOKUYAMA CORPORATION (JP) 2010-06-01 US disclosed
US-7728154-B2 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one TOKUYAMA CORPORATION (JP) 2010-06-01 US disclosed
US-20080200697-A1 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one TOKUYAMA CORPORATION (JP) 2008-08-21 US disclosed
US-20080200697-A1 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one TOKUYAMA CORPORATION (JP) 2008-08-21 US disclosed
US-20080200697-A1 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one TOKUYAMA CORPORATION (JP) 2008-08-21 US disclosed
EP-1955992-A2 Process for the preparation of 1-aryl-3, 4-dihydro-1h-napthalene-2-one TOKUYAMA CORPORATION (JP) 2008-08-13 EP disclosed
EP-1955992-A2 Process for the preparation of 1-aryl-3, 4-dihydro-1h-napthalene-2-one TOKUYAMA CORPORATION (JP) 2008-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200697-A1 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one SULT1E1, CYP2S1, SULT1A1 GID4 4052/4885MAPT 4045/4885HPGD 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.